بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
content decreased » content increased (توسيع البحث), content increases (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
content decreased » content increased (توسيع البحث), content increases (توسيع البحث)
-
641
Construction of transgenic <i>D</i>. <i>parva</i> overexpressing <i>DpAP2</i> gene.
منشور في 2024الموضوعات: -
642
-
643
-
644
-
645
-
646
-
647
Contents of PIO Program.
منشور في 2025"…The difference between the two groups was statistically significant (<i>t</i> = 3.94, <i>p</i><.001). Depression decreased -0.7±3.48 in the experimental group, from 5.9±4.74 before intervention to 5.2±4.65 after intervention, and decreased by -0.2±3.42, from 6.5±4.69 before intervention to 6.4±4.08 after intervention, in the control group, but the difference between the two groups was not statistically significant (<i>z</i> = -0.59, <i>p</i> =.557). …"
-
648
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
منشور في 2024"…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …"
-
649
-
650
-
651
-
652
-
653
-
654
-
655
-
656
-
657
-
658
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
منشور في 2025"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
-
659
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
منشور في 2025"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
-
660